Royal Bank Of Canada Profound Medical Corp. Transaction History

Royal Bank Of Canada

$528 Billion
Q2 2025

A detailed history of Royal Bank Of Canada transactions in Profound Medical Corp. stock. As of the latest transaction made, Royal Bank Of Canada holds 459,919 shares of PROF stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

459,919

Previous 435,997 5.49%

Holding current value

$1.87 Million

Previous $2.54 Million 6.94%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.04 - $6.86 $96,644 - $164,104	23,922 Added 5.49%	459,919 $2.71 Million
Q1 2025 May 15, 2025	BUY	$5.81 - $7.9 $85,958 - $116,880	14,795 Added 3.51%	435,997 $2.54 Million
Q4 2024 Feb 14, 2025	BUY	$6.98 - $8.96 $138,741 - $178,097	19,877 Added 4.95%	421,202 $3.16 Million
Q3 2024 Nov 14, 2024	BUY	$7.47 - $11.18 $717 - $1,073	96 Added 0.02%	401,325 $3.19 Million
Q2 2024 Aug 14, 2024	BUY	$7.25 - $9.07 $7,996 - $10,004	1,103 Added 0.28%	401,229 $3.37 Million
Q1 2024 Nov 05, 2024	SELL	$7.3 - $9.46 $8,051 - $10,434	-1,103 Reduced 0.27%	400,126 $3.41 Million
Q1 2024 May 15, 2024	SELL	$7.3 - $9.46 $240 - $312	-33 Reduced 0.01%	400,126 $3.41 Million
Q4 2023 Feb 14, 2024	SELL	$7.85 - $11.18 $13,140 - $18,715	-1,674 Reduced 0.42%	400,159 $3.4 Million
Q3 2023 Nov 14, 2023	BUY	$7.91 - $13.27 $9,120 - $15,300	1,153 Added 0.29%	401,833 $4.1 Million
Q2 2023 Aug 14, 2023	SELL	$9.27 - $14.88 $2,910 - $4,672	-314 Reduced 0.08%	400,680 $5.21 Million
Q1 2023 May 15, 2023	BUY	$8.85 - $13.27 $12,159 - $18,232	1,374 Added 0.34%	400,994 $3.73 Million
Q4 2022 Feb 14, 2023	BUY	$3.18 - $10.91 $41,340 - $141,830	13,000 Added 3.36%	399,620 $4.35 Million
Q3 2022 Nov 14, 2022	SELL	$3.99 - $9.3 $1,540 - $3,589	-386 Reduced 0.1%	386,620 $1.56 Million
Q2 2022 Aug 15, 2022	BUY	$6.34 - $9.53 $414,033 - $622,356	65,305 Added 20.3%	387,006 $2.82 Million
Q1 2022 May 16, 2022	BUY	$8.16 - $11.33 $489,583 - $679,777	59,998 Added 22.93%	321,701 $2.9 Million
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $92,662 - $135,690	8,927 Added 3.53%	261,703 $2.94 Million
Q3 2021 Nov 15, 2021	BUY	$13.6 - $17.88 $11,505 - $15,126	846 Added 0.34%	252,776 $3.7 Million
Q2 2021 Aug 16, 2021	BUY	$16.0 - $20.59 $4.03 Million - $5.19 Million	251,930 New	251,930 $4.12 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

12.6M

Call Options Held

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $84.9M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Profound Medical Corp. Transaction History